Stachteas, P.; Nasoufidou, A.; Karagiannidis, E.; Patoulias, D.; Karakasis, P.; Alexiou, S.; Samaras, A.; Zormpas, G.; Stavropoulos, G.; Tsalikakis, D.;
et al. The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review. J. Clin. Med. 2024, 13, 5408.
https://doi.org/10.3390/jcm13185408
AMA Style
Stachteas P, Nasoufidou A, Karagiannidis E, Patoulias D, Karakasis P, Alexiou S, Samaras A, Zormpas G, Stavropoulos G, Tsalikakis D,
et al. The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review. Journal of Clinical Medicine. 2024; 13(18):5408.
https://doi.org/10.3390/jcm13185408
Chicago/Turabian Style
Stachteas, Panagiotis, Athina Nasoufidou, Efstratios Karagiannidis, Dimitrios Patoulias, Paschalis Karakasis, Sophia Alexiou, Athanasios Samaras, Georgios Zormpas, George Stavropoulos, Dimitrios Tsalikakis,
and et al. 2024. "The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review" Journal of Clinical Medicine 13, no. 18: 5408.
https://doi.org/10.3390/jcm13185408
APA Style
Stachteas, P., Nasoufidou, A., Karagiannidis, E., Patoulias, D., Karakasis, P., Alexiou, S., Samaras, A., Zormpas, G., Stavropoulos, G., Tsalikakis, D., Kassimis, G., Papadopoulos, C., & Fragakis, N.
(2024). The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review. Journal of Clinical Medicine, 13(18), 5408.
https://doi.org/10.3390/jcm13185408
